Concepedia

Robin Katie Kelley

RK

13

Publications

829

Citations

11

H-Index

2012

Active since

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

Mayo Clinic in Florida

The University of Texas MD Anderson Cancer Center

WinnMed

Robin Katie Kelley is an author at University of California, San Francisco specializing in cancer therapeutics, medicine, and pharmacology.

Top concepts

Publications per year

2012–2023

13

Publications

13

Biliary cancer: Utility of next‐generation sequencing for clinical management

Milind Javle, Tanios Bekaii‐Saab, Apurva Jain et al. · Cancer · 2016 · 393 citations · Full text

Activity of cabozantinib (XL184) in hepatocellular carcinoma: Results from a phase II randomized discontinuation trial (RDT).

Chris Verslype, Allen Lee Cohn, Robin Katie Kelley et al. · Journal of Clinical Oncology · 2012 · 109 citations

, , +16

Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.

Celina Ang, Robin Katie Kelley, Michael A. Choti et al. · PubMed · 2013 · 104 citations · Full text

Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures

Kabir Mody, Prerna Jain, Sherif El-Refai et al. · JCO Precision Oncology · 2022 · 60 citations · Full text

A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies

A. Jo Chien, Alyson Cockerill, Craig Fancourt et al. · Breast Cancer Research and Treatment · 2016 · 31 citations

, , +7

Rows per page

1–5 of 13